Moreover, a meta-analysis revealed that factors such as age, education, comorbidities, BMI, albumin levels, nutritional status, symptom clusters, depression, and daily living abilities significantly influence frailty in oncology patients [7]. This evidence concerns the gene ALB and depressive symptom measurement.